SciVision Biotech Inc. announced earnings results for the third quarter ended September 30, 2019. For the third quarter, the company announced sales was TWD 102.812 million compared to TWD 73.159 million a year ago. Operating income was TWD 28.086 million compared to TWD 10.307 million a year ago. Net income was TWD 25.685 million compared to TWD 16.147 million a year ago. Basic earnings per share was TWD 0.44 compared to TWD 0.31 a year ago. For the nine months, sales was TWD 308.062 million compared to TWD 227.948 million a year ago. Operating income was TWD 87.568 million compared to TWD 50.893 million a year ago. Net income was TWD 80.841 million compared to TWD 55.343 million a year ago. Basic earnings per share was TWD 1.4 compared to TWD 1.06 a year ago. Diluted earnings per share was TWD 1.36 compared to TWD 1.06 a year ago.